Search

everythinglearnresearchcommunity

for

Search:↓

Certain gene variations in PITX2 are linked to a higher risk of male pattern baldness in Indians.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Oral minoxidil effectively treats hair loss, with women needing lower doses (0.25 to 2.5 mg daily) and men needing higher doses (1.25 to 5 mg daily).

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

About 41% of Indian hair loss patients have low enzyme activity that affects hair loss treatment effectiveness, with men affected more than women. Testing for this can guide treatment.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Smoking increases the risk and severity of male pattern baldness.

Androgenetic alopecia can be treated with minoxidil and finasteride, requiring long-term use and patient cooperation.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

Conflicting findings in androgenic alopecia are likely due to biopsy location, hair diameter diversity, and hair follicle miniaturization.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Radiation-induced alopecia after angioembolization usually heals on its own and can look like other hair loss types, but patient history helps prevent misdiagnosis.

Hair transplantation effectively treats burn scar alopecia, improving self-esteem and confidence.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

Valproic acid can cause hair loss when taken orally but may promote hair growth when applied topically.

Androgenetic alopecia is linked to a higher risk of varicose veins, especially in men, but not to major vascular diseases.

Stress worsens hair loss in androgenetic alopecia.

Scalp tissue micrografts can effectively treat hair loss by increasing hair density and thickness.

The FUE technique is a popular, less invasive option for hair transplant with quicker recovery and fewer scars compared to other methods.

Platelet-rich plasma therapy shows promise in treating hair loss caused by androgenic alopecia.

Hair loss in Saudi Arabia causes a low psychosocial impact, with less effect on those without a family history of hair loss.

Stem cell therapies could be a promising alternative for hair loss treatment, but more research is needed to understand their full potential and safety.

Botulinum toxin-A injections in the scalp can reduce hair loss and promote new hair growth in men with certain types of baldness.

Clove oil nanoemulsion hair serum may effectively treat hair loss.

A new method using fat tissue cells may help treat hair loss.

Combining PRP with a special lotion is more effective for hair loss than PRP alone.

Finasteride reduces hair follicle cell death in androgenetic alopecia.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.